EPN 0.00% 2.4¢ epsilon healthcare limited

article, page-626

  1. 3,034 Posts.
    lightbulb Created with Sketch. 571
    I somewhat agree, but last thing we want is fluff announcements. Nothing worst, trying too hard & looking silly.

    Like you say isn't 2017 anymore & only thing IMO that'll excite investors is product leaving Southport on an international course & THC bottom line getting FAT.

    personally I prefer 5min sit down interviews over 50 words social media posts, but I'm old skool.

    re; Endoca into NZ, 1st shipment sold out, enough said.

    CMP revenue is nice n handy, but hardly appealing to investors as overall we're still burning more than earning.

    I agree more could be said about cultivation activities at Bundy, 2nd, 3rd or 4th harvest, types of strains, improvement of CBD levels, maybe want to keep that info under wraps, I understand.

    They have mentioned Asian ties, basically a shake of hands, nothing concrete yet.

    Off-takes yes we all agree, nobody wanting to ann this more than Ken & Co themselves, it'll come, you know & I know it.

    cheers for detailed thorough post.
 
watchlist Created with Sketch. Add EPN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.